| 000 | 00979ngm a2200217 454500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20170531113415.0 | ||
| 008 | 140223b2013 xxu||||| |||| 00| 0 eng d | ||
| 020 | _c0.00 | ||
| 040 | _c | ||
| 082 |
_a615.19 _bCHA |
||
| 100 |
_aChangela, Neel Girish _913027 |
||
| 245 | _aPharmacophore Modeling, Virtual Screening, Molecular Docking and in Silico Admet Study of Anaplastic Lymphoma Kinase (Alk) Inhibitors | ||
| 260 |
_aAhmedabad _bInstitute of Pharmacy, Nirma University _c2013 |
||
| 300 | _a56p | ||
| 500 | _aGuided by Mr. Vivek K. Vyas | ||
| 600 |
_aPharmaceutical Chemistry _9370 |
||
| 856 | _uftp://10.1.15.150/B.Pharm%20Project/2013%20B.Pharm%20Project/PPR00429%20-%20Pharmacophore%20Modeling,%20Virtual%20Screening,%20Molecular%20Docking%20and%20in%20Silico%20Admet%20Study%20of%20Anaplastic%20Lymphoma%20Kinase%20(Alk)%20Inhibitors,%2009BPH021.pdf | ||
| 942 |
_2ddc _cPRA |
||
| 999 |
_c17173 _d17173 |
||